When omega-3 and the immune system are discussed, a common misconception arises: omega-3 "strengthens" the immune system — as if it generally increases immune activity. In reality, the opposite is closer to the truth: EPA and DHA modulate the immune system. They help regulate excessive inflammatory reactions, promote resolution of inflammation and restore immunological balance. This is a fundamentally different mechanism from immune stimulants — and has considerable clinical relevance, especially for people with autoimmune conditions, chronic inflammatory diseases or altered immune dysregulation. This page explains how EPA and DHA act on the immune system, what mechanisms underlie this, and what research shows.
Immune stimulation vs. immunomodulation: an important distinction
Popular food supplements are frequently marketed with promises to "strengthen" or "boost" the immune system. For many health conditions, however, a strong immune response is not the goal — quite the contrary: in autoimmune diseases (such as rheumatism, Hashimoto's thyroiditis, Crohn's disease, multiple sclerosis), allergic conditions or chronic inflammatory states, the problem is an excessive or misdirected immune reaction, not one that is too weak.
What does immunomodulation mean?
Immunomodulation describes the ability to influence the immune system in both directions: reinforcing a too-weak response and dampening a too-strong one — always towards a healthy balance. Omega-3 fatty acids do not act as an indiscriminate immune booster. They act on specific signalling pathways: reducing production of pro-inflammatory cytokines, promoting the formation of regulatory T cells and activating pro-resolving mediators that actively terminate inflammation.
Modulation, not stimulation
Omega-3 does not "strengthen" the immune system in the sense of increasing immune activity. EPA and DHA act as immunomodulators: they help the immune system respond appropriately — neither too little nor too much. This distinction is clinically decisive in autoimmune diseases: immune stimulation would be harmful there, while immunomodulation towards less inflammatory activity can be beneficial.
The immune system: a brief overview
To understand the effect of omega-3, a brief overview of relevant immune cells and signalling pathways is helpful:
Innate immune system
The innate immune system reacts rapidly but non-specifically to pathogens and tissue damage. Neutrophils, macrophages and natural killer (NK) cells are the main actors. Macrophages play a special role: they can differentiate into both pro-inflammatory (M1 macrophages, producing TNF-alpha, IL-1, IL-6) and anti-inflammatory (M2 macrophages, producing IL-10, TGF-beta) phenotypes. Omega-3 influences this polarisation in favour of the anti-inflammatory M2 phenotype.
Adaptive immune system
The adaptive immune system responds more slowly but with high specificity. T helper cells (CD4+) coordinate the immune response: Th1 cells stimulate cellular immunity, Th2 cells humoral immunity (antibodies), Th17 cells are involved in autoimmune processes. Regulatory T cells (Tregs) dampen excessive reactions. EPA and DHA influence the Th1/Th2/Th17/Treg balance towards less pro-inflammatory — a mechanism relevant for autoimmune diseases and allergies.
Cytokines: immune system messengers
Cytokines are signalling proteins through which immune cells communicate. Pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6, IL-17) promote inflammatory reactions; anti-inflammatory cytokines (IL-10, TGF-beta) dampen them. Omega-3 fatty acids influence the cytokine balance at multiple levels — both through direct inhibition of the arachidonic acid cascade and through the formation of specialised pro-resolving lipid mediators.
Scientific evidence: what does research on omega-3 and immune function show?
Research on omega-3 and immune function is multifaceted: from cell culture studies to animal studies and clinical intervention trials. Two particularly relevant works:
Calder PC: Immunomodulation by omega-3 — mechanisms in detail
Philip Calder's widely cited mechanistic review summarises how EPA and DHA act on the immune system: (1) through incorporation into immune cell membranes and modification of membrane fluidity and receptor expression, (2) through influence on the transcription factor NF-kappaB and thus gene expression of pro-inflammatory mediators, (3) through formation of specialised pro-resolving lipid mediators (resolvins, protectins, maresins) and (4) through PPAR-gamma activation. Calder emphasises: the effect of omega-3 on the immune system is complex and bidirectional — depending on context and dose.
Gao et al.: 32 meta-analyses — reduction of inflammatory markers as immunological effect
The umbrella meta-analysis by Gao et al. (2022), pooling 32 prior meta-analyses, documents the clinical measurability of immunomodulation: significant reduction in CRP (ES = −0.40; P < 0.001), TNF-alpha (ES = −0.23; P = 0.002) and IL-6 (ES = −0.22; P = 0.010). These markers are not just indicators of inflammation, but direct immune mediators: TNF-alpha and IL-6 are cytokines acting centrally in immune signalling. Their reduction by omega-3 reflects direct immunomodulatory effects.
Resolvins and protectins: the body's own resolution programme
One of the most fascinating discoveries of modern immunology is the identification of specialised pro-resolving lipid mediators (SPMs) — a family of lipid molecules formed directly from EPA and DHA. The most important representatives are resolvins (from EPA: E-series; from DHA: D-series), protectins (also neuroprotectins, from DHA) and maresins (also from DHA).
What do resolvins do?
Resolvins are not simple anti-inflammatories — they are coordinators of resolution. Their most important functions in the immune system:
- Promoting neutrophil apoptosis: Exhausted neutrophils are guided towards controlled apoptosis, rather than disintegrating necrotically (which would generate new inflammatory stimuli).
- Stimulating macrophage phagocytosis: Macrophages are activated to absorb apoptotic neutrophils and cellular debris (efferocytosis) — this actively terminates the inflammatory stimulus.
- Regulating cytokine production: Resolvins inhibit the release of pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6) and promote the release of anti-inflammatory mediators (IL-10).
- Restoring tissue homeostasis: They signal to the tissue to return to its normal state after inflammation resolves.
Protectins (neuroprotectins)
Protectins are formed primarily from DHA. They protect tissues from excessive inflammatory damage, inhibit neutrophil migration into tissues and have neuroprotective properties. In the context of immunomodulation, they are particularly relevant for the brain (where DHA is found in high concentration) and for regulating inflammatory processes in the nervous system.
SPMs: why this goes beyond "anti-inflammatory"
Classical anti-inflammatories such as NSAIDs or corticosteroids passively suppress inflammatory processes. SPMs formed from EPA and DHA (resolvins, protectins, maresins) instead actively activate cellular programmes that resolve inflammation and repair tissue. This is an immunologically different approach — and explains why omega-3 does not act in an immunosuppressive way, but in an immunomodulatory one.
Omega-3 and autoimmune diseases
In autoimmune diseases, the immune system attacks the body's own structures. The underlying problem is impaired immune tolerance. Omega-3 can intervene at several points of this dysregulation:
Rheumatoid arthritis
In RA, the immune system produces antibodies against joint structures and releases pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6, IL-17) that cause joint damage. Studies show that omega-3 can reduce these cytokines and decrease NSAID requirements — more information on the page Omega-3 for rheumatism and arthritis.
Systemic lupus erythematosus (SLE)
Several small clinical studies and epidemiological data suggest that omega-3 may moderately reduce inflammatory markers and disease activity (measured by SLEDAI score) in SLE. The data are less robust than in RA, but consistent in direction. Larger RCTs are lacking.
Crohn's disease and ulcerative colitis
In inflammatory bowel disease (IBD), there is a rationale for omega-3: EPA and DHA reduce inflammatory markers in the gut and influence the gut microbiota towards greater diversity. A Cochrane review (pooling several studies) on omega-3 and IBD showed mixed results — in Crohn's disease, no consistent remission maintenance; in ulcerative colitis, some positive signals for certain parameters. Research is ongoing here.
Multiple sclerosis
DHA is found in high concentration in myelin sheaths and nerve cell membranes. Epidemiological data show an inverse association between fish consumption and MS incidence in certain populations. Clinical intervention studies are smaller and more heterogeneous, but show signs of reduced inflammatory markers and possibly slowed disease progression. Robust meta-analyses are lacking.
Omega-3, immune cells and cellular mechanisms
| Immune cell / Structure | Effect of EPA/DHA | Mechanism |
|---|---|---|
| Macrophages (M1) | Fewer pro-inflammatory cytokines (TNF-alpha, IL-6) | Membrane composition, NF-kappaB inhibition |
| Macrophages (M2) | Promotes anti-inflammatory polarisation | PPAR-gamma activation |
| Neutrophils | Reduced migration into tissue | Resolvins inhibit chemotaxis |
| Exhausted neutrophils | Orderly apoptosis rather than necrosis | Resolvin E1 promotes apoptosis |
| Regulatory T cells (Tregs) | Promotes differentiation | Cytokine network modulation |
| Th17 cells | Reduction in autoimmune stimulation | IL-17 signalling pathway modulation |
| Dendritic cells | Modified antigen presentation | Membrane fluidity, lipid rafts |
| B cells (antibodies) | Modulation of antibody production | Cytokine network effects |
EPA vs. DHA: who acts where in the immune system?
EPA and DHA have different profiles in immunomodulation:
EPA: more potent in cytokine reduction and eicosanoid modulation
EPA is the direct competitor of arachidonic acid in eicosanoid synthesis. From EPA, prostaglandins of series 3 and leukotrienes of series 5 are formed — both considerably less pro-inflammatory than arachidonic acid products (series 2 and 4 respectively). EPA is also the primary source of E-series resolvins. For cytokine reduction (TNF-alpha, IL-6), EPA-predominant formulations show more consistent effects.
DHA: membrane incorporation, neuroprotectin, structural immune action
DHA is preferentially incorporated into immune cell membranes and modifies their physical properties — fluidity, lipid raft formation (microdomains serving as platforms for receptor signalling). DHA is the source of protectins and D-series resolvins, as well as maresins. In the brain, DHA is found in especially high concentration — hence DHA has particular importance for neuroinflammatory processes.
Omega-3 and infection defence: what do we know?
A frequent question is whether omega-3's immunomodulatory effect impairs defence against infections. This concern is understandable: if omega-3 dampens inflammatory reactions, this could theoretically also impair infection defence.
Available evidence provides no convincing indication of this. Omega-3 does not inhibit the acute immune response against infectious agents. The immunomodulatory effect is directed primarily at excessive and chronic inflammatory reactions — not at primary recognition and fighting of pathogens. Some studies even suggest that omega-3 may improve NK cell function and vaccine response by optimising the membrane composition of immune cells.
During the COVID-19 pandemic, the role of omega-3 was intensively debated. A Danish cohort study showed that omega-3 supplementation was associated with reduced risk of severe COVID-19 courses. A role of SPMs (resolvins) in resolving hyperinflammatory reactions (cytokine storm) was mechanistically discussed. However, causal conclusions cannot be drawn from observational studies.
Omega-3 and vaccines
Several studies have investigated whether omega-3 influences vaccine response. The evidence is mixed: some studies show improved antibody titres after influenza vaccination with omega-3 supplementation; others show no difference. There is no evidence that omega-3 impairs vaccine response. Taking omega-3 around the time of vaccination is not contraindicated.
The omega-6/omega-3 ratio and immune health
The effect of omega-3 on the immune system cannot be considered in isolation — it is closely linked to the ratio of omega-6 to omega-3 in the diet. In a Western diet, this ratio is typically 15:1 to 20:1 (omega-6 to omega-3). This means arachidonic acid dominates in immune cell membranes — and with it, the pro-inflammatory eicosanoids derived from it.
An increase in omega-3 intake improves the ratio in favour of EPA and DHA. The goal is not to eliminate omega-6 entirely — linoleic acid and arachidonic acid are essential fatty acids with important functions. The aim is to restore an immune cell membrane composition that allows both acute defence responses and orderly resolution of inflammation.
More information on the omega-6 to omega-3 ratio can be found on the page Omega-3 vs omega-6: the right ratio.
Who benefits most from omega-3 supplementation for the immune system?
Based on available scientific evidence, the following groups are particularly relevant:
| Population group | Relevance | Quality of evidence |
|---|---|---|
| People with RA or autoimmune diseases | Cytokine reduction, anti-inflammatory, NSAID sparing | Good (several meta-analyses) |
| People with chronically elevated inflammatory markers | CRP, IL-6, TNF-alpha reduction | Very good (umbrella meta-analysis) |
| Older adults (inflammaging) | Counteracting chronic low-grade inflammation | Moderate |
| Elite athletes (training inflammation) | Faster recovery times, DOMS reduction | Moderate (some RCTs) |
| People with metabolic syndrome | Visceral fat produces pro-inflammatory cytokines | Good |
| Pregnant women (foetal immune programming) | Child's immune development, allergy prevention | Moderate–Good |
Practical assessment
Omega-3 is neither an immune stimulant nor an immunosuppressant. It is an immunomodulator that helps promote immunological balance. This distinction is clinically important: for people with excessive immune reactions (autoimmune diseases, allergies, chronic inflammation), the immunomodulatory effect of omega-3 can be beneficial — not because it suppresses the immune system, but because it promotes orderly resolution of inflammatory processes.
Omega-3 does not replace any immunotherapy or specific medication. As a component of a balanced diet and healthy lifestyle, it can contribute measurably to immune health. The scientific evidence is strongest for effects on inflammatory markers — for specific autoimmune diseases beyond RA, larger studies are needed.
More information on the specific inflammatory mechanisms of EPA and DHA on the page Omega-3 and inflammation: how EPA and DHA act. On the application for joint inflammation, see the page Omega-3 for rheumatism and arthritis.
Frequently asked questions
Can omega-3 weaken the immune system?
No. Omega-3 fatty acids do not suppress the immune system. They modulate it towards a more balanced immune response. The immunomodulatory effect primarily concerns chronic and excessive inflammatory reactions — not the primary defence against infectious agents. There is no evidence in studies that normal doses of omega-3 impair defence against infections.
Is omega-3 safe in autoimmune diseases?
Available evidence shows no signs of negative effects of omega-3 in autoimmune diseases such as RA, lupus or IBD. On the contrary: several studies show potential benefits in RA (pain reduction, marker reduction). If you take immunomodulators or biologics, dosage should be coordinated with your treating specialist — not due to known risks, but due to lack of interaction data at high doses.
What are resolvins and which foods contain them?
Resolvins are not nutrients found directly in foods — the body synthesises them from EPA and DHA. This means you do not consume resolvins, but EPA and DHA as precursors, from which the body produces resolvins (and protectins, maresins). Sources of EPA and DHA are oily fish (salmon, mackerel, herring, sardines), algae oil (vegan alternative) and concentrated fish oil supplements.
Does omega-3 affect vaccine efficacy?
There is no evidence that omega-3 makes vaccines less effective. Some studies even show improved antibody titres after influenza vaccination with omega-3 intake; others show no difference. Taking omega-3 around the time of vaccination is not contraindicated. If in doubt, consult your doctor — but no pharmacological interactions between omega-3 and vaccines have been documented.
How much EPA+DHA is needed for immunomodulatory effects?
Most studies on inflammatory markers (CRP, IL-6, TNF-alpha) as a measure of immunomodulatory effect showed effects with 1–3 g EPA+DHA per day. The umbrella meta-analysis (Gao et al. 2022) showed significant CRP reductions across a broad dosage spectrum. For specific autoimmune diseases such as RA, doses of 2.7–6 g/day were used. What matters is product concentration: only EPA+DHA content counts, not total capsule quantity.
Note for patients on immunosuppression
Patients taking immunosuppressants (e.g. after organ transplant) should discuss omega-3 supplementation at higher doses with their transplant physician. Although no direct interactions have been documented, caution is advisable with any change in supplementation. At low to moderate doses (up to 2 g EPA+DHA/day), the risk is very low according to current knowledge.
Medical disclaimer
This article is for general information purposes only and does not replace medical advice. All health statements are based on EFSA-authorised health claims and published scientific studies. Omega-3 supplements are food supplements and are not a substitute for a balanced diet or medical treatment. In the event of existing conditions, especially autoimmune diseases, or use of immunomodulators, always consult a doctor.